144 related articles for article (PubMed ID: 35690576)
1. COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records.
Thygesen JH; Tomlinson C; Hollings S; Mizani MA; Handy A; Akbari A; Banerjee A; Cooper J; Lai AG; Li K; Mateen BA; Sattar N; Sofat R; Torralbo A; Wu H; Wood A; Sterne JAC; Pagel C; Whiteley WN; Sudlow C; Hemingway H; Denaxas S;
Lancet Digit Health; 2022 Jul; 4(7):e542-e557. PubMed ID: 35690576
[TBL] [Abstract][Full Text] [Related]
2. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
3. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
Mathur R; Rentsch CT; Morton CE; Hulme WJ; Schultze A; MacKenna B; Eggo RM; Bhaskaran K; Wong AYS; Williamson EJ; Forbes H; Wing K; McDonald HI; Bates C; Bacon S; Walker AJ; Evans D; Inglesby P; Mehrkar A; Curtis HJ; DeVito NJ; Croker R; Drysdale H; Cockburn J; Parry J; Hester F; Harper S; Douglas IJ; Tomlinson L; Evans SJW; Grieve R; Harrison D; Rowan K; Khunti K; Chaturvedi N; Smeeth L; Goldacre B;
Lancet; 2021 May; 397(10286):1711-1724. PubMed ID: 33939953
[TBL] [Abstract][Full Text] [Related]
4. Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.
Wood A; Denholm R; Hollings S; Cooper J; Ip S; Walker V; Denaxas S; Akbari A; Banerjee A; Whiteley W; Lai A; Sterne J; Sudlow C;
BMJ; 2021 Apr; 373():n826. PubMed ID: 33827854
[TBL] [Abstract][Full Text] [Related]
5. Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform.
Nab L; Parker EPK; Andrews CD; Hulme WJ; Fisher L; Morley J; Mehrkar A; MacKenna B; Inglesby P; Morton CE; Bacon SCJ; Hickman G; Evans D; Ward T; Smith RM; Davy S; Dillingham I; Maude S; Butler-Cole BFC; O'Dwyer T; Stables CL; Bridges L; Bates C; Cockburn J; Parry J; Hester F; Harper S; Zheng B; Williamson EJ; Eggo RM; Evans SJW; Goldacre B; Tomlinson LA; Walker AJ;
Lancet Public Health; 2023 May; 8(5):e364-e377. PubMed ID: 37120260
[TBL] [Abstract][Full Text] [Related]
6. Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England.
Nafilyan V; Islam N; Mathur R; Ayoubkhani D; Banerjee A; Glickman M; Humberstone B; Diamond I; Khunti K
Eur J Epidemiol; 2021 Jun; 36(6):605-617. PubMed ID: 34132940
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study.
Hippisley-Cox J; Khunti K; Sheikh A; Nguyen-Van-Tam JS; Coupland CAC
BMJ; 2023 Jun; 381():e072976. PubMed ID: 37343968
[TBL] [Abstract][Full Text] [Related]
8. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
Agrawal U; Katikireddi SV; McCowan C; Mulholland RH; Azcoaga-Lorenzo A; Amele S; Fagbamigbe AF; Vasileiou E; Grange Z; Shi T; Kerr S; Moore E; Murray JLK; Shah SA; Ritchie L; O'Reilly D; Stock SJ; Beggs J; Chuter A; Torabi F; Akbari A; Bedston S; McMenamin J; Wood R; Tang RSM; de Lusignan S; Hobbs FDR; Woolhouse M; Simpson CR; Robertson C; Sheikh A
Lancet Respir Med; 2021 Dec; 9(12):1439-1449. PubMed ID: 34599903
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
[TBL] [Abstract][Full Text] [Related]
12. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.
Gao M; Piernas C; Astbury NM; Hippisley-Cox J; O'Rahilly S; Aveyard P; Jebb SA
Lancet Diabetes Endocrinol; 2021 Jun; 9(6):350-359. PubMed ID: 33932335
[TBL] [Abstract][Full Text] [Related]
13. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
[TBL] [Abstract][Full Text] [Related]
14. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
15. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
Aktaa S; Wu J; Nadarajah R; Rashid M; de Belder M; Deanfield J; Mamas MA; Gale CP
Thromb Res; 2021 Jun; 202():17-23. PubMed ID: 33711754
[TBL] [Abstract][Full Text] [Related]
16. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.
Williamson EJ; McDonald HI; Bhaskaran K; Walker AJ; Bacon S; Davy S; Schultze A; Tomlinson L; Bates C; Ramsay M; Curtis HJ; Forbes H; Wing K; Minassian C; Tazare J; Morton CE; Nightingale E; Mehrkar A; Evans D; Inglesby P; MacKenna B; Cockburn J; Rentsch CT; Mathur R; Wong AYS; Eggo RM; Hulme W; Croker R; Parry J; Hester F; Harper S; Douglas IJ; Evans SJW; Smeeth L; Goldacre B; Kuper H
BMJ; 2021 Jul; 374():n1592. PubMed ID: 34261639
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
Murthy S; Archambault PM; Atique A; Carrier FM; Cheng MP; Codan C; Daneman N; Dechert W; Douglas S; Fiest KM; Fowler R; Goco G; Gu Y; Guerguerian AM; Hall R; Hsu JM; Joffe A; Jouvet P; Kelly L; Kho ME; Kruisselbrink RJ; Kumar D; Kutsogiannis DJ; Lamontagne F; Lee TC; Menon K; O'Grady H; O'Hearn K; Ovakim DH; Pharand SG; Pitre T; Reel R; Reeve B; Rewa O; Richardson D; Rishu A; Sandhu G; Sarfo-Mensah S; Shadowitz E; Sligl W; Solomon J; Stelfox HT; Swanson A; Tessier-Grenier H; Tsang JLY; Wood G;
CMAJ Open; 2021; 9(1):E181-E188. PubMed ID: 33688026
[TBL] [Abstract][Full Text] [Related]
18. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
19. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
[TBL] [Abstract][Full Text] [Related]
20. Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study.
Wong CKH; Au ICH; Lau KTK; Lau EHY; Cowling BJ; Leung GM
Lancet Infect Dis; 2022 Dec; 22(12):1681-1693. PubMed ID: 36029795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
